Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Why does Covid-19 continue to spread despite mass vaccination

Bibliographic Data

ID22091513
AuthorsShuo Zhang (0000-0002-7812-4260, Shaanxi University of Chinese Medicine), Zhen Yang (0000-0003-4056-0347, Shaanxi University of Chinese Medicine), Zhen-Lin Chen (0000-0002-4075-4128, Shaanxi University of Chinese Medicine, corresponding author), Shi-Jun Yue (0000-0003-2097-223X, Shaanxi University of Chinese Medicine), Sai Zhang (0000-0002-6622-2592, Beijing University of Chinese Medicine), Yu-Ping Tang (0000-0002-1272-057X, Shaanxi University of Chinese Medicine, corresponding author)
Year2022
Volume10
Pages938108-938108
Publication date2022-07-25
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2022.938108
PMID35958834
OpenAlexW4287219223
LanguageEN
Citations received1
References cited35

According to the data released by World Health Organization (WHO), 182 COVID-19 vaccines have entered the pre-clinical trial stage, of which 73 have entered the clinical research stage, and 21 have entered the clinical phase III or phase I II/III (4). Depending on the target and the technology used in preparation, vaccines can be divided Frontiers in Public Health frontiersin.org

2019-20 coronavirus outbreak · Environmental health · Mass vaccination · Outbreak · Pandemic · Pathology · Political science · Public health · Public opinion · Vaccination · COVID-19 Clinical Research Studies · Long-Term Effects of COVID-19 · Medicine · SARS-CoV-2 and COVID-19 Research · Virology

  • Evolving trend change during the Covid-19 pandemic

    Open Access•Liping Gao, Canjun Zheng et al.•Frontiers in Public Health•2022

  • The epidemiology and pathogenesis of coronavirus disease (Covid-19) outbreak

    Open Access•Hussin A Rothan, Siddappa N Byrareddy•Journal of Autoimmunity•2020

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2

    Open Access•Merryn Voysey, Sue Ann Costa Clemens et al.•The Lancet•2021

Unique citing works1
Citations per year0.25
Citation span2022 - 2022 (1)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 1

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae